絞り込み

16355

広告

803件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Determination of edoxaban equivalent concentrations in human plasma by an automated anti-factor Xa chromogenic assay.

An Open-Label Crossover Study of the Pharmacokinetics of the 60-mg Edoxaban Tablet Crushed and Administered Either by a Nasogastric Tube or in Apple Puree in Healthy Adults.

Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far?

Safety of The Direct Oral Anticoagulant Edoxaban for Atrial Fibrillation After Cardiac Surgery: Pilot Study.

Appropriateness of Oral Anticoagulants for the Long-Term Treatment of Atrial Fibrillation in Older People: Results of an Evidence-Based Review and International Consensus Validation Process (OAC-FORTA 2016).

Direct Oral Anticoagulants versus Enoxaparin for Prevention of Venous Thromboembolism Following Orthopedic Surgery: A Dose-Response Meta-analysis.

Risk of gastrointestinal bleeding during anticoagulant treatment.

Incidence and predictors of silent cerebral thromboembolic lesions after catheter ablation for atrial fibrillation in patients treated with direct oral anticoagulants.

Thrombosis in an Internal Jugular Vein and an Upper Limb Deep Vein Treated with Edoxaban.

Risk of Gastrointestinal Bleeding in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants: a Systematic Review and Meta-analysis.

Assessment of Direct Oral Anticoagulant Prescribing and Monitoring Pre- and Post-Implementation of a Pharmacy Protocol at a Community Teaching Hospital.

Use of direct oral anticoagulants for the prevention and treatment of thromboembolic disease in patients with reduced renal function: a short review of the clinical evidence.

[Treatment and Secondary Prevention of Venous Thromboembolism - Change in Oral Anticoagulation].

Laboratory monitoring or measurement of direct oral anticoagulants (DOACs): Advantages, limitations and future challenges.

Management of bleeding or urgent interventions in patients treated with direct oral anticoagulants (DOACs) - 2017 management proposals in Poland.

[New oral anticoagulants in patients with atrial fibrillation: efficacy and safety data from the real world].

The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review.

Pharmacological secondary prevention in patients with mesenterial artery atherosclerosis and arterial embolism.

Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan.

Direct Oral Anticoagulants in the Treatment of Venous Thromboembolic Disease.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります